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Introduction
CINCA syndrome, also known as NOMID, is a rare auto-
inflammatory disease caused by the NLRP3 mutations. It
has been known that conventional genetic analysis failed
to detect disease-causing mutations in approximately
40% of patients. We have recently identified NLRP3
somatic mosaicism on 70% of these ”mutation-negative”
patients in the international collaborative study (Tanaka
N. and Izawa K. et al., Arthritis Rheum, 2011), and found
no significant differences on systemic inflammation
between heterozygous germline mutations and somatic
mosaicism. This raises a question how a small number of
NLRP3-mutated cells cause systemic inflammation as
severely as 100% of germline mutations.
Objectives
To solve the question, we analyzed cytokine production
from the single cells, especially IL-1b which is the key
molecule of NLRP3 inflammasome. There are the 2 forms
of IL-1b, namely preform and mature forms, and only the
latter is said to be secreted. Although the IL-1b in the sin-
gle cell can be measured by intracellular cytokine staining,
the relationship of the amount of intracellular IL-1b in the
single cells and secreted IL-1b from them is still unknown.
From these issues, it would be a better approach to mea-
sure the secreted IL-1b at a single cell level.
Methods
In this work, we tried to establish a single cell fluorescent
immunoassay system to measure IL-1b secretion from
monocytes of CINCA/NOMID patients at a single cell level
using a soft lithographic method called microengraving.
Results
In the healthy control, very small number of cells secreted
low amount of IL-1b by the LPS stimulation. In contrast,
significant number of cells secreted high amount of IL-1b
by the LPS stimulation in CINCA/NOMID patients with
heterozygous germline mutations. We were also able to
observe a large number of IL-1b secreting cells from
patients with somatic mosaic mutations by LPS stimula-
tion alone.
To delineate whether only the cells with a mutation on
NLRP3 are responsible for IL-1b secretion in the mosaics,
we pick up the single cells from the microwells positive
on IL-1b secretion by micromanipulator. By performing
genetic analysis on them, we are now trying to determine
whether only the mutated cells secrete IL-1b or the small
fraction of NLRP3-mutated cells causes in vivo bystander
activation of the wild type monocytes in the somatic
mosaic CINCA/NOMID patients.
In addition, this method could be offered to diagnose
the somatic mosaicism of CINCA/NOMID easily on the
basis of single cell functional analysis, which would com-
plement the DNA sequencing based method (Izawa K.
and Hijikata A. et al., DNA research, 2012) that might
miss some rare CINCA/NOMID cases caused by other
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